Report overview
This report contains market size and forecasts of Antibody Development Services in Global, including the following market information:
Global Antibody Development Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antibody Development Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibody Development Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antibody Development Services include Thermo Fisher Scientific, R&D Systems, Leinco Technologies, Rockland Immunochemicals, Inc. (Rockland), Bio-Rad, BioGenes, ProteoGenix, Labcorp and Inotiv, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antibody Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibody Development Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antibody Development Services Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibody Development
Polyclonal Antibody Development
Global Antibody Development Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antibody Development Services Market Segment Percentages, by Application, 2021 (%)
Medical Industry
Biological Industry
Others
Global Antibody Development Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antibody Development Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antibody Development Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antibody Development Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
R&D Systems
Leinco Technologies
Rockland Immunochemicals, Inc. (Rockland)
Bio-Rad
BioGenes
ProteoGenix
Labcorp
Inotiv, Inc.
ProMab Biotechnologies
Kemp Proteins
Synaptic Systems
ARVYS Proteins, Inc.
BBI Solutions
Innovagen AB
BIOTEM
Medimab
OriGene
Abeomics Inc.
RayBiotech
Genscript Biotech Corporation
Sino Biological
Abzena Ltd
Creative Biolabs
Abcam
Antibodies Incorporated
